Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01137643 · ClinicalTrials.gov registry record
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
A clinical trial of Lymphoma and Leukemia, sponsored by UNC Lineberger Comprehensive Cancer Center.
- Recruiting
- Registry status
- 15,000
- Enrollment target
- 1
- Study location
NCT01137643 is a study of Lymphoma and Leukemia that is actively recruiting participants, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 15,000 participants, above the 434-participant average among 299 other Lymphoma trials with a reported enrollment target (3356% higher). The trial reports 1 study location across 1 state.
The verdict
NCT01137643, a study of Lymphoma and Leukemia, is actively recruiting participants, sponsored by UNC Lineberger Comprehensive Cancer Center.
- RECRUITING
- Registry status
- 15,000 participants
- Enrollment target
- 1
- Study location
Study Summary
RATIONALE: Collecting and storing samples of tissue, blood, and body fluid from patients with cancer to study in the laboratory may help the study of cancer in the future. PURPOSE: This research study is collecting and storing blood and tissue samples from patients being evaluated for hematologic cancer.
Conditions Studied
Interventions
- OTHER biologic sample preservation procedure
- OTHER cytology specimen collection procedure
Study Locations (1)
North Carolina
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15,000 participants |
| Start Date | 2009-07 |
| Est. Completion | 2040-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01137643
The ClinicalTrials.gov registry entry for NCT01137643 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 15,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 434-participant average among 299 other Lymphoma trials with a reported enrollment target (3356% higher). The listed sponsor is UNC Lineberger Comprehensive Cancer Center, which has 366 total studies on file at ClinicalTrials.gov.
The record links to 8 conditions, with Lymphoma appearing as the primary indexed condition, and to 2 interventions - of which biologic sample preservation procedure is the first listed.
NCT01137643 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT01137643 about?
NCT01137643 is a clinical study titled "Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer". RATIONALE: Collecting and storing samples of tissue, blood, and body fluid from patients with cancer to study in the laboratory may help the study of cancer in the future. PURPOSE: This research study is collecting and storing blood and tissue samples from patients being evaluated for hematologic c...
What is the current status of trial NCT01137643?
This trial is currently recruiting. The enrollment target is 15,000 participants. The study started on 2009-07. Estimated completion is 2040-07.
What conditions does trial NCT01137643 study?
This clinical trial studies the following conditions: Lymphoma, Leukemia, Myelodysplastic Syndromes, Multiple Myeloma and Plasma Cell Neoplasm, Chronic Myeloproliferative Disorders.
What interventions are being tested in trial NCT01137643?
The interventions under investigation include: biologic sample preservation procedure (OTHER), cytology specimen collection procedure (OTHER).
Who is sponsoring clinical trial NCT01137643?
This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01137643 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lymphoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers
RECRUITING · NA
-
Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy
RECRUITING · Phase 2
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Exercise as an Immune Adjuvant for Allogeneic Cell Therapies
RECRUITING · Early Phase 1
-
A Phase 1/2, Open-label Study of Valemetostat in Combination With Rituximab and Lenalidomide in Relapsed or Refractory Follicular Lymphoma
RECRUITING · Phase 1
-
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.